Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure

Core Article Summary - Tevogen Bio Holdings Inc expands its AI-focused collaboration with Microsoft to enhance its PredicTcell technology, leveraging Microsoft's AI, cloud capabilities, and health/life sciences expertise to accelerate target identification and pre-clinical processes [1] - The collaboration aims to strengthen Tevogen Bio's pipeline of innovative immunotherapies for infectious diseases and cancers [1] TevogenAI and Microsoft Integration - TevogenAI integrates Microsoft's advanced AI tools and Azure cloud platform to achieve two key objectives: 1) Rapidly expand the ExacTcell™ Technology Pre-Clinical Pipeline by using machine learning for critical simulations to accelerate new target identification [2] 2) Develop proprietary algorithms to decode HLA-T cell interactions, enhancing understanding of immune responses and opening new therapeutic avenues [3] Strategic Goals and Leadership Perspective - The expanded relationship with Microsoft is seen as a milestone in revolutionizing immunotherapy, with a focus on delivering precise and personalized treatments at an accelerated pace [4] - Tevogen Bio is proactively investigating potential treatments for HPV using its proprietary ExacTcell™ technology, aiming to deliver an HPV-specific CTL treatment [4] Company Overview - Tevogen Bio is a clinical-stage specialty immunotherapy company developing off-the-shelf, genetically unmodified precision T cell therapies for infectious diseases, cancers, and neurological disorders [5] - The company has reported positive safety data from its proof-of-concept clinical trial and owns key intellectual property assets, including three granted patents and nine pending US patents [5] - Tevogen Bio is led by a team of experienced industry leaders and scientists, emphasizing accessible personalized therapeutics and disruptive business models to sustain medical innovation [6] Additional Notes - The collaboration with Microsoft is part of the previously announced Microsoft for Startups program [7] - PredicTcell, Tevogen Bio's proprietary technology, is designed for predictive, precision T cell target identification [7]